Covid-19 man­u­fac­tur­ing roundup: NY biotech primed to be­come Im­mu­ni­ty­Bio's drug sub­stance gold­mine; Illi­nois set to meet de­mand for at-home tests

A Buf­fa­lo, NY drug man­u­fac­tur­ing site that was fund­ed with $200 mil­lion of state mon­ey could soon be­come Im­mu­ni­ty­Bio’s largest man­u­fac­tur­er of Covid-19 vac­cine drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER